Profile data is unavailable for this security.
About the company
Transcenta Holding Limited is a China-based investment holding company engaged in the discovery, research, development, manufacturing and business development of biopharmaceuticals in the clinical stage. The Company's products include MSB2311, TST001, TST005, TST002, TST004, TST003, TST008, MSB0254 and TST006. The Company's all products are in the research and development (R&D) stage and have not been commercialized. The Company also provides contract developmentand manufacturing organization (CDMO) services, mainly including process development services, GMP / cGMP production services, cell line development services, sample testing services, formula optimization services and drug formation research.
- Revenue in HKD (TTM)58.26m
- Net income in HKD-500.47m
- Incorporated2010
- Employees215.00
- LocationTranscenta Holding LimitedB6-501, Biobay, 218 Xinghu StreetSUZHOU 215123ChinaCHN
- Websitehttps://www.transcenta.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sirnaomics Ltd | 0.00 | -616.24m | 508.30m | 145.00 | -- | 1.61 | -- | -- | -8.10 | -8.10 | 0.00 | 3.59 | 0.00 | -- | -- | 0.00 | -70.91 | -- | -71.22 | -- | -- | -- | -- | -- | -- | -- | 0.6176 | -- | -- | -- | 10.88 | -- | -- | -- |
| Uni-Bio Science Group Ltd | 484.72m | 70.88m | 511.58m | 407.00 | 7.45 | 2.05 | 5.83 | 1.06 | 0.0111 | 0.0111 | 0.0762 | 0.0404 | 1.38 | 2.62 | 9.44 | 1,190,953.00 | 20.18 | 1.46 | 28.50 | 1.97 | 81.04 | 80.59 | 14.62 | 1.23 | 1.76 | 97.93 | 0.1796 | -- | 10.08 | 29.08 | 84.04 | -- | -- | -- |
| Tianda Pharmaceuticals Ltd | 532.09m | -24.16m | 559.01m | 863.00 | -- | 0.9442 | 43.92 | 1.05 | -0.0112 | -0.0112 | 0.2475 | 0.2754 | 0.5306 | 4.88 | 4.37 | 616,557.40 | -2.49 | -- | -3.84 | -- | 48.02 | -- | -4.70 | -- | 0.8907 | -10.16 | 0.161 | -- | -- | -- | -- | -- | -- | -- |
| Antengene Corporation Ltd | 72.82m | -628.80m | 560.16m | 201.00 | -- | 0.4512 | -- | 7.69 | -1.02 | -1.02 | 0.1184 | 1.84 | 0.0358 | 0.9773 | 3.41 | 362,283.90 | -30.91 | -53.57 | -36.46 | -58.94 | 81.74 | -- | -863.51 | -1,987.01 | 6.43 | -- | 0.1491 | -- | -57.97 | -- | 3.38 | -- | -- | -- |
| Genor Biopharma Holdings Ltd | 0.00 | -729.61m | 589.41m | 104.00 | -- | 0.4538 | -- | -- | -1.44 | -1.44 | 0.00 | 2.53 | 0.00 | 0.00 | -- | 0.00 | -37.91 | -55.46 | -44.02 | -63.73 | -- | 66.56 | -- | -14,819.18 | 5.38 | -- | 0.006 | -- | -100.00 | -- | 7.65 | -- | -- | -- |
| Fusen Pharmaceutical Co Ltd | 611.95m | -39.25m | 637.46m | 1.15k | -- | 1.05 | 17.70 | 1.04 | -0.0526 | -0.0526 | 0.8137 | 0.8134 | 0.4199 | 1.95 | 4.47 | 533,054.30 | -2.69 | 0.9678 | -5.54 | 1.74 | 52.95 | 51.95 | -6.42 | 2.59 | 0.6096 | 0.71 | 0.3797 | -- | 15.02 | 4.13 | -4.83 | -- | -- | -- |
| Pak Fah Yeow International Ltd | 259.16m | 105.04m | 638.86m | 102.00 | 6.08 | 0.8349 | 5.68 | 2.47 | 0.337 | 0.337 | 0.8315 | 2.46 | 0.2995 | 2.88 | 15.52 | 2,540,765.00 | 12.14 | 3.99 | 12.60 | 4.18 | 84.45 | 80.79 | 40.53 | 21.27 | 6.90 | 10.03 | 0.0062 | 66.94 | 76.06 | 12.94 | 250.66 | 23.02 | -- | -8.06 |
| Lee's Pharmaceutical Holdings Ltd | 1.05bn | 16.70m | 683.05m | 1.06k | 40.90 | 0.335 | 4.03 | 0.6487 | 0.0284 | 0.0284 | 1.79 | 3.46 | 0.3713 | 1.83 | 10.75 | -- | 0.7033 | 13.33 | 0.88 | 17.76 | 52.35 | 61.92 | 1.89 | 36.20 | 0.5526 | 3.65 | 0.0943 | 5.43 | -14.61 | -1.53 | -67.44 | -47.49 | -- | -31.34 |
| JW (Cayman) Therapeutics Co Ltd | 188.10m | -830.92m | 712.70m | 398.00 | -- | 0.3894 | -- | 3.79 | -2.02 | -2.02 | 0.4571 | 4.42 | 0.0704 | 1.88 | 65.54 | 472,611.60 | -31.11 | -39.77 | -35.21 | -44.00 | 50.74 | -- | -441.74 | -1,316.81 | 3.90 | -11.83 | 0.1592 | -- | 19.32 | -- | 9.23 | -- | -- | -- |
| Transcenta Holding Limited | 58.26m | -500.47m | 733.11m | 215.00 | -- | 0.6576 | -- | 12.58 | -1.23 | -1.23 | 0.1431 | 2.55 | 0.0281 | 2.05 | 1.25 | 270,979.80 | -24.17 | -- | -33.97 | -- | 26.74 | -- | -859.01 | -- | 1.20 | -66.53 | 0.285 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
| Brii Biosciences Ltd | 667.55k | -189.15m | 758.82m | 128.00 | -- | 0.2248 | -- | 1,136.73 | -0.26 | -0.26 | 0.0009 | 4.63 | 0.0002 | -- | -- | 5,215.22 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
| Jbm (Healthcare) Ltd | 610.30m | 97.99m | 759.09m | 258.00 | 8.38 | 0.8091 | 5.10 | 1.24 | 0.1087 | 0.1087 | 0.6786 | 1.12 | 0.4406 | 5.88 | 4.10 | 2,000,994.00 | 7.56 | 3.33 | 9.04 | 4.93 | 47.70 | 45.97 | 17.17 | 10.97 | 1.45 | 22.15 | 0.1211 | 13.81 | 28.11 | 14.51 | 131.90 | 6.14 | -5.09 | -- |
| Hbm Holdings Ltd | 700.91m | 178.53m | 800.95m | 154.00 | 4.16 | 0.8505 | 3.73 | 1.14 | 0.2497 | 0.2497 | 0.9703 | 1.22 | 0.3886 | 3.90 | 3.01 | 4,551,351.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -- | -- |
| Zhaoke Ophthalmology Ltd | 20.29m | -416.58m | 846.52m | 313.00 | -- | 0.382 | -- | 41.73 | -0.7659 | -0.7659 | 0.0373 | 4.06 | 0.0075 | -- | 0.3433 | 64,811.89 | -15.43 | -- | -17.27 | -- | 75.98 | -- | -2,053.54 | -- | 5.32 | -47.54 | 0.1041 | -- | -- | -- | 5.47 | -- | -- | -- |
| VIVA Biotech Holdings | 2.33bn | -125.63m | 896.97m | 2.08k | -- | 0.2228 | 7.41 | 0.3846 | -0.0639 | -0.0639 | 1.20 | 1.86 | 0.2805 | 4.84 | 5.13 | 1,122,858.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 0.035 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | -- | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 910.49m | 160.35m | 1.01bn | 848.00 | 6.29 | 0.6296 | 8.21 | 1.11 | 0.2862 | 0.2862 | 1.63 | 2.86 | 0.3587 | 2.18 | 2.94 | 1,073,691.00 | 6.32 | 7.67 | 9.12 | 10.48 | 69.40 | 78.79 | 17.61 | 20.68 | 1.51 | -- | 0.0515 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
Data as of Apr 23 2024. Currency figures normalised to Transcenta Holding Limited's reporting currency: Hong Kong Dollar HKD
5.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullerton Fund Management Co. Ltd.as of 30 Jun 2023 | 26.02m | 5.96% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
